Pharmaceutical compositions for combination therapy

Pharmaceutical compositions for combination therapy

This invention relates to novel pharmaceutical compositions comprising a therapeutically effective combination of a dopaminergic stabilizer known as Pridopidine, and an inhibitor of the vesicular monoamine transporter type 2 (VMAT) known as Tetrabenazine. The pharmaceutical compositions for use acco...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: WATERS EVA SUSANNA, WATERS ROSS NICHOLAS
Format: Patent
Sprache:eng ; heb
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator WATERS EVA SUSANNA
WATERS ROSS NICHOLAS
description This invention relates to novel pharmaceutical compositions comprising a therapeutically effective combination of a dopaminergic stabilizer known as Pridopidine, and an inhibitor of the vesicular monoamine transporter type 2 (VMAT) known as Tetrabenazine. The pharmaceutical compositions for use according to the invention are contemplated particularly useful for improving the symptomatic therapeutic effects, and for reducing the adverse effects, of Tetrabenazine in the treatment of movement disorders, and in articular movement disorders associated with Huntington's disease, Gilles de la Tourette's syndrome, or tardive dyskinesia.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_IL234831A0</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>IL234831A0</sourcerecordid><originalsourceid>FETCH-epo_espacenet_IL234831A03</originalsourceid><addsrcrecordid>eNrjZDAOyEgsyk1MTi0tyUxOzFFIzs8tyC_OLMnMzytWSMsvAgkkZeYlggQUSjJSixILKnkYWNMSc4pTeaE0N4O8m2uIs4duakF-fGpxAdC0vNSSeE8fI2MTC2NDRwNjwioArIgsaQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Pharmaceutical compositions for combination therapy</title><source>esp@cenet</source><creator>WATERS EVA SUSANNA ; WATERS ROSS NICHOLAS</creator><creatorcontrib>WATERS EVA SUSANNA ; WATERS ROSS NICHOLAS</creatorcontrib><description>This invention relates to novel pharmaceutical compositions comprising a therapeutically effective combination of a dopaminergic stabilizer known as Pridopidine, and an inhibitor of the vesicular monoamine transporter type 2 (VMAT) known as Tetrabenazine. The pharmaceutical compositions for use according to the invention are contemplated particularly useful for improving the symptomatic therapeutic effects, and for reducing the adverse effects, of Tetrabenazine in the treatment of movement disorders, and in articular movement disorders associated with Huntington's disease, Gilles de la Tourette's syndrome, or tardive dyskinesia.</description><language>eng ; heb</language><creationdate>2014</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20141231&amp;DB=EPODOC&amp;CC=IL&amp;NR=234831A0$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20141231&amp;DB=EPODOC&amp;CC=IL&amp;NR=234831A0$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>WATERS EVA SUSANNA</creatorcontrib><creatorcontrib>WATERS ROSS NICHOLAS</creatorcontrib><title>Pharmaceutical compositions for combination therapy</title><description>This invention relates to novel pharmaceutical compositions comprising a therapeutically effective combination of a dopaminergic stabilizer known as Pridopidine, and an inhibitor of the vesicular monoamine transporter type 2 (VMAT) known as Tetrabenazine. The pharmaceutical compositions for use according to the invention are contemplated particularly useful for improving the symptomatic therapeutic effects, and for reducing the adverse effects, of Tetrabenazine in the treatment of movement disorders, and in articular movement disorders associated with Huntington's disease, Gilles de la Tourette's syndrome, or tardive dyskinesia.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2014</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDAOyEgsyk1MTi0tyUxOzFFIzs8tyC_OLMnMzytWSMsvAgkkZeYlggQUSjJSixILKnkYWNMSc4pTeaE0N4O8m2uIs4duakF-fGpxAdC0vNSSeE8fI2MTC2NDRwNjwioArIgsaQ</recordid><startdate>20141231</startdate><enddate>20141231</enddate><creator>WATERS EVA SUSANNA</creator><creator>WATERS ROSS NICHOLAS</creator><scope>EVB</scope></search><sort><creationdate>20141231</creationdate><title>Pharmaceutical compositions for combination therapy</title><author>WATERS EVA SUSANNA ; WATERS ROSS NICHOLAS</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_IL234831A03</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; heb</language><creationdate>2014</creationdate><toplevel>online_resources</toplevel><creatorcontrib>WATERS EVA SUSANNA</creatorcontrib><creatorcontrib>WATERS ROSS NICHOLAS</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>WATERS EVA SUSANNA</au><au>WATERS ROSS NICHOLAS</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Pharmaceutical compositions for combination therapy</title><date>2014-12-31</date><risdate>2014</risdate><abstract>This invention relates to novel pharmaceutical compositions comprising a therapeutically effective combination of a dopaminergic stabilizer known as Pridopidine, and an inhibitor of the vesicular monoamine transporter type 2 (VMAT) known as Tetrabenazine. The pharmaceutical compositions for use according to the invention are contemplated particularly useful for improving the symptomatic therapeutic effects, and for reducing the adverse effects, of Tetrabenazine in the treatment of movement disorders, and in articular movement disorders associated with Huntington's disease, Gilles de la Tourette's syndrome, or tardive dyskinesia.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; heb
recordid cdi_epo_espacenet_IL234831A0
source esp@cenet
title Pharmaceutical compositions for combination therapy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T14%3A58%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=WATERS%20EVA%20SUSANNA&rft.date=2014-12-31&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EIL234831A0%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true